Stockreport

Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on Natural Killer (NK) Cells

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF -- Collaboration to Leverage oNKo-innate’s Deep Expertise in NK Cell Tumor Biology to Discover Novel Therapies in Immuno-Oncology and Cell Therapy -- FOSTER CITY, Cal [Read more]